Radiomicrosphere Dosimetry: Principles and Current State of the Art
Radiomicrosphere Therapy (RMT) refers to a liver-directed therapeutic modality based on the intrahepatic arterial administration of radiolabeled microspheres. There is a need for standardization of the terminology of RMT. A descriptive identifier should first name the radioisotope, then the chemical...
Gespeichert in:
| Veröffentlicht in: | Seminars in nuclear medicine 2022-03, Vol.52 (2), p.215-228 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 228 |
|---|---|
| container_issue | 2 |
| container_start_page | 215 |
| container_title | Seminars in nuclear medicine |
| container_volume | 52 |
| creator | Gulec, Seza A. McGoron, Anthony J. |
| description | Radiomicrosphere Therapy (RMT) refers to a liver-directed therapeutic modality based on the intrahepatic arterial administration of radiolabeled microspheres. There is a need for standardization of the terminology of RMT. A descriptive identifier should first name the radioisotope, then the chemical formulation of the microsphere, and lastly add the term RMT that indicates the therapeutic modality. At present, clinically available options include |Y-90| |Resin| |RMT|, |Y-90| |Glass| |RMT| and |Ho-166| |PLLA| |RMT|. The latter is available in Europe and is being considered for clearance by the FDA in the United States. Preclinical studies with |Re-188| |PLLA| |RMT| are underway. Dosimetric considerations are strongly tied to both the type of the radioisotope and the chemical composition of the microsphere type. This review will focus on Y-90 resin and glass RMT, the history, dosimetry, clinical use, and controversies. |
| doi_str_mv | 10.1053/j.semnuclmed.2021.12.009 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2628298569</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0001299821001100</els_id><sourcerecordid>2628298569</sourcerecordid><originalsourceid>FETCH-LOGICAL-c374t-17371f2df89f19a6118c489e2b2edf95c6348000df800a32541b94112fd214ee3</originalsourceid><addsrcrecordid>eNqFkMlOwzAQhi0EoqXwCshHLgkeJ05tbhBWqRKI5WylzkR1lQ3bQerbk6qtOHKaw3z_LB8hFFgMTCTX69hj0w6mbrCMOeMQA48ZU0dkCkLIKM14ckymjDGIuFJyQs68XzPGhVDilEwSAamUaj4l-XtR2q6xxnW-X6FDet9522Bwmxv65mxrbF-jp0Vb0nxwDttAP0IRkHYVDSukty6ck5OqqD1e7OuMfD0-fObP0eL16SW_XUQmmachgnkyh4qXlVQVqCIDkCaVCvmSY1kpYbIklePJI8BYkXCRwlKlALwqOaSIyYxc7eb2rvse0AfdWG-wrosWu8FrnnHJlRSZGlG5Q7d_eYeV7p1tCrfRwPRWoV7rP4V6q1AD16PCMXq53zIst71D8OBsBO52AI6__lh02huLrcHSOjRBl539f8sv9nCGnA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2628298569</pqid></control><display><type>article</type><title>Radiomicrosphere Dosimetry: Principles and Current State of the Art</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Gulec, Seza A. ; McGoron, Anthony J.</creator><creatorcontrib>Gulec, Seza A. ; McGoron, Anthony J.</creatorcontrib><description>Radiomicrosphere Therapy (RMT) refers to a liver-directed therapeutic modality based on the intrahepatic arterial administration of radiolabeled microspheres. There is a need for standardization of the terminology of RMT. A descriptive identifier should first name the radioisotope, then the chemical formulation of the microsphere, and lastly add the term RMT that indicates the therapeutic modality. At present, clinically available options include |Y-90| |Resin| |RMT|, |Y-90| |Glass| |RMT| and |Ho-166| |PLLA| |RMT|. The latter is available in Europe and is being considered for clearance by the FDA in the United States. Preclinical studies with |Re-188| |PLLA| |RMT| are underway. Dosimetric considerations are strongly tied to both the type of the radioisotope and the chemical composition of the microsphere type. This review will focus on Y-90 resin and glass RMT, the history, dosimetry, clinical use, and controversies.</description><identifier>ISSN: 0001-2998</identifier><identifier>EISSN: 1558-4623</identifier><identifier>DOI: 10.1053/j.semnuclmed.2021.12.009</identifier><identifier>PMID: 35148897</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Embolization, Therapeutic ; Humans ; Liver Neoplasms - drug therapy ; Microspheres ; Radioisotopes ; Radiometry ; Rhenium ; Yttrium Radioisotopes - therapeutic use</subject><ispartof>Seminars in nuclear medicine, 2022-03, Vol.52 (2), p.215-228</ispartof><rights>2022 Elsevier Inc.</rights><rights>Copyright © 2022 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c374t-17371f2df89f19a6118c489e2b2edf95c6348000df800a32541b94112fd214ee3</citedby><cites>FETCH-LOGICAL-c374t-17371f2df89f19a6118c489e2b2edf95c6348000df800a32541b94112fd214ee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0001299821001100$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35148897$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gulec, Seza A.</creatorcontrib><creatorcontrib>McGoron, Anthony J.</creatorcontrib><title>Radiomicrosphere Dosimetry: Principles and Current State of the Art</title><title>Seminars in nuclear medicine</title><addtitle>Semin Nucl Med</addtitle><description>Radiomicrosphere Therapy (RMT) refers to a liver-directed therapeutic modality based on the intrahepatic arterial administration of radiolabeled microspheres. There is a need for standardization of the terminology of RMT. A descriptive identifier should first name the radioisotope, then the chemical formulation of the microsphere, and lastly add the term RMT that indicates the therapeutic modality. At present, clinically available options include |Y-90| |Resin| |RMT|, |Y-90| |Glass| |RMT| and |Ho-166| |PLLA| |RMT|. The latter is available in Europe and is being considered for clearance by the FDA in the United States. Preclinical studies with |Re-188| |PLLA| |RMT| are underway. Dosimetric considerations are strongly tied to both the type of the radioisotope and the chemical composition of the microsphere type. This review will focus on Y-90 resin and glass RMT, the history, dosimetry, clinical use, and controversies.</description><subject>Embolization, Therapeutic</subject><subject>Humans</subject><subject>Liver Neoplasms - drug therapy</subject><subject>Microspheres</subject><subject>Radioisotopes</subject><subject>Radiometry</subject><subject>Rhenium</subject><subject>Yttrium Radioisotopes - therapeutic use</subject><issn>0001-2998</issn><issn>1558-4623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMlOwzAQhi0EoqXwCshHLgkeJ05tbhBWqRKI5WylzkR1lQ3bQerbk6qtOHKaw3z_LB8hFFgMTCTX69hj0w6mbrCMOeMQA48ZU0dkCkLIKM14ckymjDGIuFJyQs68XzPGhVDilEwSAamUaj4l-XtR2q6xxnW-X6FDet9522Bwmxv65mxrbF-jp0Vb0nxwDttAP0IRkHYVDSukty6ck5OqqD1e7OuMfD0-fObP0eL16SW_XUQmmachgnkyh4qXlVQVqCIDkCaVCvmSY1kpYbIklePJI8BYkXCRwlKlALwqOaSIyYxc7eb2rvse0AfdWG-wrosWu8FrnnHJlRSZGlG5Q7d_eYeV7p1tCrfRwPRWoV7rP4V6q1AD16PCMXq53zIst71D8OBsBO52AI6__lh02huLrcHSOjRBl539f8sv9nCGnA</recordid><startdate>202203</startdate><enddate>202203</enddate><creator>Gulec, Seza A.</creator><creator>McGoron, Anthony J.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202203</creationdate><title>Radiomicrosphere Dosimetry: Principles and Current State of the Art</title><author>Gulec, Seza A. ; McGoron, Anthony J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c374t-17371f2df89f19a6118c489e2b2edf95c6348000df800a32541b94112fd214ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Embolization, Therapeutic</topic><topic>Humans</topic><topic>Liver Neoplasms - drug therapy</topic><topic>Microspheres</topic><topic>Radioisotopes</topic><topic>Radiometry</topic><topic>Rhenium</topic><topic>Yttrium Radioisotopes - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gulec, Seza A.</creatorcontrib><creatorcontrib>McGoron, Anthony J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Seminars in nuclear medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gulec, Seza A.</au><au>McGoron, Anthony J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Radiomicrosphere Dosimetry: Principles and Current State of the Art</atitle><jtitle>Seminars in nuclear medicine</jtitle><addtitle>Semin Nucl Med</addtitle><date>2022-03</date><risdate>2022</risdate><volume>52</volume><issue>2</issue><spage>215</spage><epage>228</epage><pages>215-228</pages><issn>0001-2998</issn><eissn>1558-4623</eissn><abstract>Radiomicrosphere Therapy (RMT) refers to a liver-directed therapeutic modality based on the intrahepatic arterial administration of radiolabeled microspheres. There is a need for standardization of the terminology of RMT. A descriptive identifier should first name the radioisotope, then the chemical formulation of the microsphere, and lastly add the term RMT that indicates the therapeutic modality. At present, clinically available options include |Y-90| |Resin| |RMT|, |Y-90| |Glass| |RMT| and |Ho-166| |PLLA| |RMT|. The latter is available in Europe and is being considered for clearance by the FDA in the United States. Preclinical studies with |Re-188| |PLLA| |RMT| are underway. Dosimetric considerations are strongly tied to both the type of the radioisotope and the chemical composition of the microsphere type. This review will focus on Y-90 resin and glass RMT, the history, dosimetry, clinical use, and controversies.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>35148897</pmid><doi>10.1053/j.semnuclmed.2021.12.009</doi><tpages>14</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0001-2998 |
| ispartof | Seminars in nuclear medicine, 2022-03, Vol.52 (2), p.215-228 |
| issn | 0001-2998 1558-4623 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2628298569 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Embolization, Therapeutic Humans Liver Neoplasms - drug therapy Microspheres Radioisotopes Radiometry Rhenium Yttrium Radioisotopes - therapeutic use |
| title | Radiomicrosphere Dosimetry: Principles and Current State of the Art |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T05%3A28%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Radiomicrosphere%20Dosimetry:%20Principles%20and%20Current%20State%20of%20the%20Art&rft.jtitle=Seminars%20in%20nuclear%20medicine&rft.au=Gulec,%20Seza%20A.&rft.date=2022-03&rft.volume=52&rft.issue=2&rft.spage=215&rft.epage=228&rft.pages=215-228&rft.issn=0001-2998&rft.eissn=1558-4623&rft_id=info:doi/10.1053/j.semnuclmed.2021.12.009&rft_dat=%3Cproquest_cross%3E2628298569%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2628298569&rft_id=info:pmid/35148897&rft_els_id=S0001299821001100&rfr_iscdi=true |